Strapped Small Chinese Drug Firms Losing Market Share
This article was originally published in PharmAsia News
Executive Summary
As competition intensifies in China's pharmaceutical market, many state-owned drug giants are selling their drugs at below-cost prices to capture as many Class III hospital clients as possible